BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9504042)

  • 1. What are the molecular mechanisms of neural tube defects?
    Corcoran J
    Bioessays; 1998 Jan; 20(1):6-8. PubMed ID: 9504042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inositol- and folate-resistant neural tube defects in mice lacking the epithelial-specific factor Grhl-3.
    Ting SB; Wilanowski T; Auden A; Hall M; Voss AK; Thomas T; Parekh V; Cunningham JM; Jane SM
    Nat Med; 2003 Dec; 9(12):1513-9. PubMed ID: 14608380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific isoforms of protein kinase C are essential for prevention of folate-resistant neural tube defects by inositol.
    Cogram P; Hynes A; Dunlevy LP; Greene ND; Copp AJ
    Hum Mol Genet; 2004 Jan; 13(1):7-14. PubMed ID: 14613966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into prevention of human neural tube defects by folic acid arising from consideration of mouse mutants.
    Harris MJ
    Birth Defects Res A Clin Mol Teratol; 2009 Apr; 85(4):331-9. PubMed ID: 19117321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inositol prevents folate-resistant neural tube defects in the mouse.
    Greene ND; Copp AJ
    Nat Med; 1997 Jan; 3(1):60-6. PubMed ID: 8986742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects.
    Harris MJ; Juriloff DM
    Birth Defects Res A Clin Mol Teratol; 2007 Mar; 79(3):187-210. PubMed ID: 17177317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mini-review: toward understanding mechanisms of genetic neural tube defects in mice.
    Harris MJ; Juriloff DM
    Teratology; 1999 Nov; 60(5):292-305. PubMed ID: 10525207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comments on inositol supplementation in pregnancies at risk of apparently folate-resistant NTDs.
    Shaw G
    Birth Defects Res A Clin Mol Teratol; 2008 Jul; 82(7):543. PubMed ID: 18428991
    [No Abstract]   [Full Text] [Related]  

  • 9. An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure.
    Harris MJ; Juriloff DM
    Birth Defects Res A Clin Mol Teratol; 2010 Aug; 88(8):653-69. PubMed ID: 20740593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward understanding the genetic basis of neural tube defects.
    Kibar Z; Capra V; Gros P
    Clin Genet; 2007 Apr; 71(4):295-310. PubMed ID: 17470131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype of the neural tube defect mouse model bent tail is not sensitive to maternal folinic acid, myo-inositol, or zinc supplementation.
    Franke B; Klootwijk R; Lemmers B; de Kovel CG; Steegers-Theunissen RP; Mariman EC
    Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):979-84. PubMed ID: 14745918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inositol supplementation in pregnancies at risk of apparently folate-resistant NTDs.
    Cavalli P; Tedoldi S; Riboli B
    Birth Defects Res A Clin Mol Teratol; 2008 Jul; 82(7):540-2. PubMed ID: 18418886
    [No Abstract]   [Full Text] [Related]  

  • 13. Mouse Fkbp8 activity is required to inhibit cell death and establish dorso-ventral patterning in the posterior neural tube.
    Wong RL; Wlodarczyk BJ; Min KS; Scott ML; Kartiko S; Yu W; Merriweather MY; Vogel P; Zambrowicz BP; Finnell RH
    Hum Mol Genet; 2008 Feb; 17(4):587-601. PubMed ID: 18003640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse models of neural tube defects: investigating preventive mechanisms.
    Greene ND; Copp AJ
    Am J Med Genet C Semin Med Genet; 2005 May; 135C(1):31-41. PubMed ID: 15800852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology, pathogenesis and prevention of neural tube defects.
    Padmanabhan R
    Congenit Anom (Kyoto); 2006 Jun; 46(2):55-67. PubMed ID: 16732763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothesis: folate-responsive neural tube defects and neurocristopathies.
    Antony AC; Hansen DK
    Teratology; 2000 Jul; 62(1):42-50. PubMed ID: 10861632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin and its receptor in the development of genetically determined neural tube defects in the mouse embryo.
    Hoyle C; Henderson DJ; Matthews DJ; Copp AJ
    Dev Dyn; 1996 Sep; 207(1):35-46. PubMed ID: 8875074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel changes in metabolite and expression profiles in crooked-tail mutant and folate-reduced wild-type mice.
    Ernest S; Carter M; Shao H; Hosack A; Lerner N; Colmenares C; Rosenblatt DS; Pao YH; Ross ME; Nadeau JH
    Hum Mol Genet; 2006 Dec; 15(23):3387-93. PubMed ID: 17050573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inositol, neural tube closure and the prevention of neural tube defects.
    Greene ND; Leung KY; Copp AJ
    Birth Defects Res; 2017 Jan; 109(2):68-80. PubMed ID: 27324558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice.
    Dawson JE; Raymond AM; Winn LM
    Toxicol Appl Pharmacol; 2006 Mar; 211(2):124-32. PubMed ID: 16112698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.